Oral Insulin May Thwart Type 1 Diabetes in High-Risk Kids

In the pilot Pre-POINT study, a high dose of oral insulin altered the immune response in children at high risk of developing type 1 diabetes; a vaccine could be 10 years away, the authors speculate.